JP2019507182A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019507182A5 JP2019507182A5 JP2018557295A JP2018557295A JP2019507182A5 JP 2019507182 A5 JP2019507182 A5 JP 2019507182A5 JP 2018557295 A JP2018557295 A JP 2018557295A JP 2018557295 A JP2018557295 A JP 2018557295A JP 2019507182 A5 JP2019507182 A5 JP 2019507182A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- composition
- use according
- chemerin
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021125537A JP2021169531A (ja) | 2016-01-22 | 2021-07-30 | 炎症を処置するための化合物および方法 |
| JP2023029552A JP7432028B2 (ja) | 2016-01-22 | 2023-02-28 | 炎症を処置するための化合物および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662286070P | 2016-01-22 | 2016-01-22 | |
| US62/286,070 | 2016-01-22 | ||
| PCT/US2017/014605 WO2017127827A1 (en) | 2016-01-22 | 2017-01-23 | Compounds and methods for treating inflammation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021125537A Division JP2021169531A (ja) | 2016-01-22 | 2021-07-30 | 炎症を処置するための化合物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019507182A JP2019507182A (ja) | 2019-03-14 |
| JP2019507182A5 true JP2019507182A5 (enExample) | 2020-03-05 |
| JP6924211B2 JP6924211B2 (ja) | 2021-08-25 |
Family
ID=57963487
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018557295A Active JP6924211B2 (ja) | 2016-01-22 | 2017-01-23 | 炎症を処置するための化合物および方法 |
| JP2021125537A Pending JP2021169531A (ja) | 2016-01-22 | 2021-07-30 | 炎症を処置するための化合物および方法 |
| JP2023029552A Active JP7432028B2 (ja) | 2016-01-22 | 2023-02-28 | 炎症を処置するための化合物および方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021125537A Pending JP2021169531A (ja) | 2016-01-22 | 2021-07-30 | 炎症を処置するための化合物および方法 |
| JP2023029552A Active JP7432028B2 (ja) | 2016-01-22 | 2023-02-28 | 炎症を処置するための化合物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US11197906B2 (enExample) |
| EP (1) | EP3405208B1 (enExample) |
| JP (3) | JP6924211B2 (enExample) |
| AU (1) | AU2017210118B2 (enExample) |
| CA (1) | CA3012190A1 (enExample) |
| ES (1) | ES2805037T3 (enExample) |
| WO (1) | WO2017127827A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10233219B2 (en) | 2013-04-12 | 2019-03-19 | Tufts Medical Center | Methods and systems for designing and/or characterizing soluble lipidated ligand agents |
| WO2017127827A1 (en) | 2016-01-22 | 2017-07-27 | Tufts Medical Center | Compounds and methods for treating inflammation |
| JP7251036B2 (ja) * | 2018-06-28 | 2023-04-04 | ポーラ化成工業株式会社 | 皮膚老化改善剤のスクリーニング方法 |
| WO2021021915A1 (en) * | 2019-08-01 | 2021-02-04 | Okyo Pharma Limited | Compositions comprising chemerin analogs and methods of use |
| WO2023220676A2 (en) * | 2022-05-12 | 2023-11-16 | Okyo Pharma Limited | Formulation for treating dry eye disease |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6416738B1 (en) | 1973-12-07 | 2002-07-09 | Neorx Corporation | Pretargeting methods and compounds |
| US5200473A (en) | 1988-03-25 | 1993-04-06 | Jeanneret Gris Gilbert | Chelating resins and method for their use in the extraction of metal ions |
| JP3507486B2 (ja) | 1991-03-15 | 2004-03-15 | アムジエン・インコーポレーテツド | 顆粒球コロニー刺激因子の肺内投与 |
| US5451569A (en) | 1994-04-19 | 1995-09-19 | Hong Kong University Of Science And Technology R & D Corporation Limited | Pulmonary drug delivery system |
| US6365156B1 (en) | 1999-04-16 | 2002-04-02 | Osel, Inc. | Method for improving the half-life of soluble viral-specific ligands on mucosal membranes |
| IL160142A0 (en) | 2001-08-17 | 2004-06-20 | Anosys Inc | Methods and compounds for the targeting of protein to exosomes |
| US7169892B2 (en) | 2003-01-10 | 2007-01-30 | Astellas Pharma Inc. | Lipid-peptide-polymer conjugates for long blood circulation and tumor specific drug delivery systems |
| US20060263336A1 (en) | 2003-03-24 | 2006-11-23 | Caplan Arnold I | Cell targeting methods and compositions |
| WO2005121755A1 (en) | 2004-06-14 | 2005-12-22 | Commonwealth Scientific And Industrial Research Organisation | Cell free g-protein coupled receptor and ligand assay |
| CN101947310A (zh) | 2004-10-27 | 2011-01-19 | 丹佛大学 | 促肾上腺皮质激素类似物以及相关方法 |
| CA2611365C (en) | 2005-06-14 | 2014-02-11 | Cellzome Ag | Process for the identification of novel enzyme interacting compounds |
| US8242058B2 (en) | 2006-07-21 | 2012-08-14 | Wisconsin Alumni Research Foundation | Reagents and methods for appending functional groups to proteins |
| JP2010229093A (ja) | 2009-03-27 | 2010-10-14 | Banyu Pharmaceut Co Ltd | 新規ＣｈｅｍｅｒｉｎＲアゴニスト |
| GB0914110D0 (en) | 2009-08-12 | 2009-09-16 | Medical Res Council | Peptide libraries |
| US20120245229A1 (en) | 2009-09-15 | 2012-09-27 | Ru-Rong Ji | Method for treating neuropathic pain |
| EP2533764A4 (en) | 2010-02-08 | 2016-08-31 | Univ Nebraska | BIOMINERAL AND METAL BINDING LIPOSOME, THEIR SYNTHESIS AND METHOD FOR THE PRODUCTION THEREOF |
| US8883177B2 (en) | 2011-06-28 | 2014-11-11 | Nian Wu | Pharmaceutical compositions for parenteral administration |
| EP2766032A4 (en) * | 2011-10-13 | 2015-04-29 | Thomas Gadek | TOPICAL FORMULATIONS OF PEPTIDES CHÉMÉRINE C15 FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS |
| US10233219B2 (en) | 2013-04-12 | 2019-03-19 | Tufts Medical Center | Methods and systems for designing and/or characterizing soluble lipidated ligand agents |
| WO2017127827A1 (en) | 2016-01-22 | 2017-07-27 | Tufts Medical Center | Compounds and methods for treating inflammation |
-
2017
- 2017-01-23 WO PCT/US2017/014605 patent/WO2017127827A1/en not_active Ceased
- 2017-01-23 CA CA3012190A patent/CA3012190A1/en active Pending
- 2017-01-23 JP JP2018557295A patent/JP6924211B2/ja active Active
- 2017-01-23 AU AU2017210118A patent/AU2017210118B2/en active Active
- 2017-01-23 EP EP17703290.1A patent/EP3405208B1/en active Active
- 2017-01-23 ES ES17703290T patent/ES2805037T3/es active Active
- 2017-01-23 US US16/070,467 patent/US11197906B2/en active Active
-
2021
- 2021-07-30 JP JP2021125537A patent/JP2021169531A/ja active Pending
- 2021-11-08 US US17/521,366 patent/US12053501B2/en active Active
-
2023
- 2023-02-28 JP JP2023029552A patent/JP7432028B2/ja active Active
-
2024
- 2024-06-20 US US18/749,154 patent/US20240325486A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019507182A5 (enExample) | ||
| US8324276B2 (en) | Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction | |
| Barnig et al. | Innate immunity is a key factor for the resolution of inflammation in asthma | |
| Hjorth et al. | Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers | |
| AU2004269903B2 (en) | The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma | |
| Liu et al. | CD31: beyond a marker for endothelial cells | |
| Recchiuti | Resolvin D1 and its GPCRs in resolution circuits of inflammation | |
| Le et al. | Parenteral fish-oil–based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition–dependent children | |
| JP2006518375A5 (enExample) | ||
| JP7432028B2 (ja) | 炎症を処置するための化合物および方法 | |
| JP2018527322A5 (enExample) | ||
| WO2014126176A1 (ja) | 炎症性疾患の予防又は治療用組成物 | |
| IL316406A (en) | Lipid-modified relaxin B peptide chains and their medical use | |
| CN102286397B (zh) | 多菌发酵剂和用于抗动脉粥样硬化的多菌发酵乳品及其生产方法 | |
| ITMI20130354A1 (it) | Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie. | |
| JP2017536380A (ja) | １５−ｈｅｐｅを含む組成物、およびそれを用いて線維症を処置または防止する方法 | |
| de Oliveira et al. | AT-RvD1 modulates the activation of bronchial epithelial cells induced by lipopolysaccharide and Dermatophagoides pteronyssinus | |
| KR20190060492A (ko) | 그래핀 양자점을 포함하는 항염증용 조성물 | |
| JP5503846B2 (ja) | アミロイドーシス関連疾患の治療のための医療品又は食料品の製造における、ｄｈａを含有する脂肪酸組成物の使用 | |
| Das | Is sepsis a pro-resolution deficiency disorder? | |
| JP2015521611A5 (enExample) | ||
| CN103476405A (zh) | 舒张性充血性心力衰竭治疗剂 | |
| JP2023546297A (ja) | 肺治療組成物 | |
| MY190709A (en) | A polypeptide from mormodica charantia for use for the regulation of genes related to inflammation, lipid and glucose metabolism | |
| JP2016523245A (ja) | Ｄｅ−ｖｄｂｐ及び不飽和脂肪酸とのビタミンｄ複合体、並びに治療法におけるその使用 |